Medical imaging artificial intelligence (AI) specialist, Avicenna.AI, recently announced that it has received certification in the U.S. and European Union (EU) for CINA CHEST, its new AI solution that leverages deep learning algorithms for emergency triage of deadly vascular conditions.
In addition to securing a CE mark in the EU, CINA CHEST has also received 510(k) clearance from the Food and Drug Administration (FDA) for its automatic detection and triage capabilities for both pulmonary embolism (PE) and aortic dissection from computed tomography (CT)-scan imaging.
CINA CHEST is part of Avicenna’s CINA family of AI tools that support the treatment of emergencies, including CINA HEAD, its FDA-cleared and CE-marked solution that supports the detection and triage of stroke and neurovascular emergencies.
“At Avicenna, we specialize in the development of AI algorithms that can identify acute abnormalities, and CINA CHEST is the latest application we have developed to enhance emergency room radiology,” said Cyril Di Grandi, co-founder and CEO of Avicenna.AI. “Our PE and aortic dissection triage tools are the third and fourth algorithms we have released in less than 12 months, demonstrating our ambition to create AI applications that support detection and triage of emergencies throughout the entire body.”